CY1118704T1 - Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου - Google Patents

Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου

Info

Publication number
CY1118704T1
CY1118704T1 CY20171100206T CY171100206T CY1118704T1 CY 1118704 T1 CY1118704 T1 CY 1118704T1 CY 20171100206 T CY20171100206 T CY 20171100206T CY 171100206 T CY171100206 T CY 171100206T CY 1118704 T1 CY1118704 T1 CY 1118704T1
Authority
CY
Cyprus
Prior art keywords
population
stem cells
catherine
human
diseases
Prior art date
Application number
CY20171100206T
Other languages
English (en)
Inventor
Piñeiro Francisco José Vizoso
Fernández Román Pérez
Díaz Noemí Eiró
Original Assignee
Gistem Research S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gistem Research S.L. filed Critical Gistem Research S.L.
Publication of CY1118704T1 publication Critical patent/CY1118704T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0661—Smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/03—Coculture with; Conditioned medium produced by non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μία μέθοδο για την απομόνωση βλαστοκυττάρων, η οποία περιλαμβάνει παρασκευή ενός κυτταρικού εναιωρήματος από ιστό τραχήλου της μήτρας, τα βλαστοκύτταρα τα οποία απομονώνονται δια της εν λόγω μεθόδου και το βελτιωμένο μέσο το οποίο λαμβάνεται από την καλλιέργεια των εν λόγω βλαστοκυττάρων. Η εφεύρεση περιλαμβάνει επίσης τη χρήση των εν λόγω βλαστοκυττάρων ή βελτιωμένου μέσου για την αγωγή ή την πρόληψη καρκίνου, φλεγμονωδών νοσημάτων, αυτοάνοσων νοσημάτων, χρόνιων παθήσεων ή μολυσματικών νοσημάτων, όπως επίσης για καλλυντική αγωγή.
CY20171100206T 2013-02-22 2017-02-15 Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου CY1118704T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13156348.8A EP2770050B1 (en) 2013-02-22 2013-02-22 Human uterine cervical stem cell population and uses thereof

Publications (1)

Publication Number Publication Date
CY1118704T1 true CY1118704T1 (el) 2017-07-12

Family

ID=47749687

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100206T CY1118704T1 (el) 2013-02-22 2017-02-15 Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου

Country Status (26)

Country Link
US (2) US20160000835A1 (el)
EP (1) EP2770050B1 (el)
JP (1) JP6453771B2 (el)
KR (1) KR102175493B1 (el)
CN (1) CN105008520B (el)
AU (1) AU2014220647B2 (el)
BR (1) BR112015020001A2 (el)
CA (1) CA2901505C (el)
CY (1) CY1118704T1 (el)
DK (1) DK2770050T3 (el)
ES (1) ES2615824T3 (el)
HK (1) HK1214300A1 (el)
HR (1) HRP20170216T1 (el)
HU (1) HUE030796T2 (el)
IL (1) IL240573B (el)
LT (1) LT2770050T (el)
MX (1) MX2015010708A (el)
NZ (1) NZ712583A (el)
PL (1) PL2770050T3 (el)
PT (1) PT2770050T (el)
RS (1) RS55656B1 (el)
RU (1) RU2679500C2 (el)
SI (1) SI2770050T1 (el)
SM (1) SMT201700114B (el)
WO (1) WO2014128291A1 (el)
ZA (1) ZA201506818B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016044421A1 (en) * 2014-09-18 2016-03-24 National Health Research Institutes Progenitor cells, method for preparation thereof and uses thereof
KR20180012223A (ko) * 2016-07-25 2018-02-05 고려대학교 산학협력단 자궁 유래 성체줄기세포 분리 및 제조 방법
US20200230172A1 (en) * 2017-02-16 2020-07-23 OCT Therapies and Research Private Limited Stem cell conditioned media for clinical and cosmetic applications
CN108865973A (zh) * 2018-06-20 2018-11-23 广西医科大学第附属医院 Sd大鼠胃窦间质细胞的分离和培养方法
AU2021267900A1 (en) * 2020-05-08 2023-01-19 Gallant Pet Inc. Uterine-derived regenerative cell compositions and uses thereof
CN112057471B (zh) * 2020-09-11 2023-12-22 复旦大学附属妇产科医院 间充质干细胞的制药用途
CN112618712A (zh) * 2021-01-21 2021-04-09 武汉轻工大学 一种含波形蛋白的佐剂及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011042547A1 (en) * 2009-10-08 2011-04-14 Projech Science To Technology, S.L. Myometrial-derived mesenchymal stem cells and uses thereof
CN102229911B (zh) * 2011-06-08 2013-09-18 山西医科大学 Sca-1+/CD34－子宫干细胞及其分离方法
RU2481585C1 (ru) * 2011-11-09 2013-05-10 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГБУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ дифференциальной диагностики лейомиосарком и пролиферирующих (клеточных) лейомиом матки

Also Published As

Publication number Publication date
IL240573A0 (en) 2015-09-24
BR112015020001A2 (pt) 2018-02-20
EP2770050B1 (en) 2016-11-16
CA2901505A1 (en) 2014-08-28
DK2770050T3 (en) 2017-02-20
ES2615824T3 (es) 2017-06-08
CN105008520B (zh) 2020-10-30
HRP20170216T1 (hr) 2017-04-21
MX2015010708A (es) 2016-06-21
KR20150133722A (ko) 2015-11-30
SI2770050T1 (sl) 2017-06-30
RU2679500C2 (ru) 2019-02-11
CN105008520A (zh) 2015-10-28
EP2770050A1 (en) 2014-08-27
RU2015139970A (ru) 2017-03-30
HK1214300A1 (zh) 2016-07-22
JP2016509834A (ja) 2016-04-04
HUE030796T2 (en) 2017-06-28
SMT201700114B (it) 2017-03-08
JP6453771B2 (ja) 2019-01-16
PT2770050T (pt) 2017-02-21
AU2014220647A1 (en) 2015-10-08
US20210299184A1 (en) 2021-09-30
KR102175493B1 (ko) 2020-11-09
US20160000835A1 (en) 2016-01-07
RS55656B1 (sr) 2017-06-30
LT2770050T (lt) 2017-04-10
CA2901505C (en) 2021-06-08
PL2770050T3 (pl) 2017-06-30
ZA201506818B (en) 2020-02-26
WO2014128291A1 (en) 2014-08-28
NZ712583A (en) 2020-05-29
AU2014220647B2 (en) 2019-06-27
IL240573B (en) 2020-01-30

Similar Documents

Publication Publication Date Title
CY1118704T1 (el) Ανθρωπινος πληθυσμος βλαστοκυτταρων του τραχηλου της μητρας και χρησεις αυτου
JOP20200192A1 (ar) أجسام مضادة لـ tigit
MX2019012233A (es) Anticuerpos anti-sirpa.
MX2022007522A (es) Anticuerpos anti-cd27.
CO2017004932A2 (es) Métodos para seleccionar una línea de células t y donador de la misma para terapia celular adoptiva
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
EA201990293A1 (ru) Мультиспецифичные антитела против cd40 и cd137
EA201790630A1 (ru) Способы получения рибозидов
EP3240551A4 (en) Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
CL2017000806A1 (es) Compuestos anti-tnf
MX2017006167A (es) Compuestos que interactúan con glicanos y métodos de uso.
EA201692473A1 (ru) Способы получения замещенных нуклеотидных аналогов
CY1125938T1 (el) Θεραπεια με βλαστοκυτταρα σε παθολογιες του ενδομητριου
MX359769B (es) Metodos para descelularizar huesos.
CL2017001135A1 (es) Anticuerpos mejorados contra il-6
EA201892568A1 (ru) Способы получения контрастных средств для ультразвукового исследования
EA201791442A1 (ru) Способы лечения гематологических нарушений, солидных опухолей или инфекционных заболеваний с применением естественных клеток-киллеров
AR120118A2 (es) Anticuerpos anti tigit
EA201990817A1 (ru) Анти-cd27 антитела
EA201992022A1 (ru) Терапевтическая рнк
EA202091619A2 (ru) Антитела против tigit